Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07659886 · ClinicalTrials.gov registry record · Phase 3
Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures
A Phase 3 study, sponsored by Atlantic Health System.
- Not yet
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT07659886 is a Phase 3 study that has not yet begun recruiting, run by Atlantic Health System. The registered enrollment target is 100 participants.
The verdict
NCT07659886, a Phase 3 study, has not yet begun recruiting, sponsored by Atlantic Health System.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.
Interventions
- DRUG Vancomycin (VAN) treatment
- OTHER Standard Open Fracture Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-06-10 |
| Est. Completion | 2027-06-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07659886
The ClinicalTrials.gov registry entry for NCT07659886 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin (VAN) treatment is the first listed.
NCT07659886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07659886 about?
NCT07659886 is a clinical study titled "Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures". To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.
What is the current status of trial NCT07659886?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2026-06-10. Estimated completion is 2027-06-10.
What interventions are being tested in trial NCT07659886?
The interventions under investigation include: Vancomycin (VAN) treatment (DRUG), Standard Open Fracture Care (OTHER).
Who is sponsoring clinical trial NCT07659886?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.